Chris Wilke’s long, strange trip has taken him back to e-clinical trials company DataTrak International Inc. in Mayfield Heights.
The former vice president at ClickFind was named in a DataTrak lawsuit last year. DataTrak claimed that ClickFind didn’t reveal important information during DataTrak’s acquisition of the Texas company in 2006. The two companies settled in Decemberafter ClickFind defendants agreed to forgo remaining payments on a $3 million promissory note.
DataTrak designs software that acts as the information platform — or “Desktop” — for people, companies and researchers doing clinical trials.
BioLabs Pegasus Park Cultivates Life Science Ecosystem
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
But since then, DataTrak Chief Executive Jeff Greene has left the company — retiring in January. Now Wilke, an architect of the ClickFind software that makes up DataTrak’s main offering, is the vice president of research and development.
Wilke will report to Ray Merk, DataTrak’s chief financial officer and chief operating officer. Wilke will be “integrally involved in the development of the DATATRAK eClinical platform,” according to a company release.
Merk stated that Wilke’s “track record of success at the company coupled with the strong partnership he has forged with our R&D team will serve DATATRAK well as we drive our business forward.”
DataTrak also announced the government approved a patent that covers methods of managing different kinds of data in one database. Wilke stated in the release that the patent will help its customers better unify different aspects of their clinical trials.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Datatrak opened today at 12 cents.
